07.06.2019 • News

Bayer Faces Roundup Lawsuit in Australia

Bayer Faces Roundup Lawsuit in Australia (c) Joerg Boethling/Alamy Stock Photo
Bayer Faces Roundup Lawsuit in Australia (c) Joerg Boethling/Alamy Stock Photo

Bayer is already facing more than US 13,000 lawsuit contending that Monsanto’s Roundup herbicide causes cancer. Now – as had been widely speculated over the past few weeks – it has its first in Australia.

Lawyers for 54-year-old self-employed landscape gardener Michael Ogalirolo said he was diagnosed with non-Hodgkin lymphoma after using Roundup for more than 20 years. All of the US lawsuits heard so far were brought by people suffering from this form of leukemia.

The writ filed by Carbone Lawyers in the supreme court of the state of Victoria on Jun. 3 alleges that Monsanto Australia failed to warn consumers that its Roundup products are dangerous to human health and could cause cancer.

The defendant knew or ought to have known that the use of Roundup products was dangerous and capable of causing serious injury, in particular causing DNA and chromosomal damage in human cells, cancer, kidney disease, infertility and nerve damage, among other devastating illnesses, the writ says.

Ogalirolo’s lawyer, Tony Carbone, told the Reuters news agency his client is seeking damages from the company for endangering his life, for loss of income and cost of care. He also wants the manufacturer to be “punished for supplying a product that is not safe.”

Bayer told Reuters it was aware of the report but had not received the writ.

The German group is not the only agrochemicals producer whose share price has suffered from the negative publicity over Roundup. Bayer’s stock market value has fallen below what it paid for Monsanto after shedding more than 40% percent since it lost its first court case in August 2018.

Reports said shares of Australia’s Nufarm dropped to a more than five-year low this week after the crop protection group said it was exposed to risk of litigation because it was a supplier of glyphosate-based herbicides.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.